Back to CVE records
High 7.5Published Sep 26, 2026

CVE-2026-100709Froxlor before 2.3.12 2FA Bypass via Namespace Confusion

Updated under an hour ago ()

Does this affect you?

It affects froxlor. Add what you run to find out whether that includes you.

EPSS puts the chance of exploitation in the next 30 days at 0.29%, higher than 19% of scored CVEs.

Froxlor through 2.3.10 stores only a numeric user ID in remembered-2FA tokens (panel_2fa_tokens) without recording the account namespace, and the remembered-token lookup during login is not constrained to the customer or administrator account type. Because customer and administrator IDs are allocated from separate namespaces, a remembered-2FA token legitimately issued to a customer with a given ID also matches an administrator with the same ID. An attacker who controls a customer account with a colliding ID, holds a valid remembered-2FA cookie for it, and already knows the target administrator's password can bypass the administrator's TOTP second factor and obtain an authenticated administrator session. This is a second-factor bypass only; it does not defeat password authentication. Fixed in 2.3.12.

CVSS
7.5 HIGH (v3.1, CNA)CVSS:3.1/AV:N/AC:H/PR:L/UI:N/S:U/C:H/I:H/A:H
Weakness (CWE)
CWE-287
Known exploited
Not in CISA's KEV catalog
EPSS (exploitation in the next 30 days)
0.29% (percentile 19)
Assigned by
VulnCheck
NVD analysis
Deferred
Record last updated
Sep 26, 2026
First seen by InfoSec Signals
Oct 9, 2026

Affected products

Affected products
froxlor froxlor
froxlor:froxlor (from the name)
before 2.3.12; 2.3.12 not affected
CNA record

References

  • vendor-advisory
  • third-party-advisory

The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.

Your cookie choices
We use essential cookies to run this site, and, only with your consent, an advertising cookie from Google to measure whether our ads lead to sign-ups and subscriptions. See our for details.